Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $3.9 million.

  • Rockwell Medical's Accumulated Expenses fell 38.55% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 38.55%. This contributed to the annual value of $6.3 million for FY2024, which is 12.23% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Accumulated Expenses is $3.9 million, which was down 5.64% from $4.1 million recorded in Q2 2025.
  • Rockwell Medical's Accumulated Expenses' 5-year high stood at $7.7 million during Q4 2022, with a 5-year trough of $3.8 million in Q2 2023.
  • Over the past 3 years, Rockwell Medical's median Accumulated Expenses value was $5.3 million (recorded in 2024), while the average stood at $5.3 million.
  • Per our database at Business Quant, Rockwell Medical's Accumulated Expenses skyrocketed by 63.91% in 2024 and then crashed by 38.55% in 2025.
  • Over the past 5 years, Rockwell Medical's Accumulated Expenses (Quarterly) stood at $5.1 million in 2021, then spiked by 51.32% to $7.7 million in 2022, then declined by 7.18% to $7.1 million in 2023, then declined by 12.23% to $6.3 million in 2024, then slumped by 38.55% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $4.1 million for Q2 2025, and $4.6 million during Q1 2025.